What if a blood test or other simple exam could one day detect Alzheimer’s? Scientists are in pursuit of ways to test for Alzheimer’s by measuring a biomarker, any substance in the body that may indicate or rule out the presence of a disease. Currently many people with Alzheimer’s are never diagnosed by a physician—or are diagnosed at a very late stage. Broad availability and adoption of a blood-based test...

For Veterans Day, our Alzheimer’s Talk focused on the Alzheimer’s risks that veterans face, the Department of Veterans Affairs research working to understand this connection, and the great VA care and services available to veterans living with Alzheimer’s, their care partners and their families. Some quick facts:

• Nearly half of America’s veterans are 65 or older, compared to just 15% of the general population, so veterans face above-average risk for...

Tangles of the protein tau in the brain are known to be a sign of Alzheimer’s, but research seeking an Alzheimer’s treatment has long been more focused on the amyloid build-up that occurs.

For 30 years, Professor Claude Wischik, co-founder and executive chairman of TauRx Therapeutics, along with his colleagues at the University of Aberdeen, has explored the structure and role of tau in the development of Alzheimer’s and...

In July, at the world’s largest gathering of Alzheimer’s researchers, the 2018 Alzheimer’s Association International Conference (AAIC), thousands of researchers gathered to discuss the latest and best in Alzheimer’s research. What does the latest research have to say about disparities in Alzheimer’s and dementia impacting diverse communities? What were the most relevant developments for those living with Alzheimer’s and their care partners?

For our August Alzheimer’s Talk, two internationally renowned...